01.03.20

New Analysis Expands on Link Between Pharma Payments, Prescribing

Source: ProPublica

Doctors who receive money from drugmakers related to a specific drug prescribe that drug more heavily than doctors without such financial ties, a new ProPublica analysis found. The pattern is consistent for almost all of the most widely prescribed brand-name drugs in Medicare, including drugs that treat diabetes, asthma and more.

The financial interactions include payments for delivering promotional talks, consulting and receiving sponsored meals and travel.

The 50 drugs in our analysis include many popular and expensive ones. Thirty-eight of the drugs have yearly costs exceeding $1,000 per patient, and many topped the list that are most costly for the Medicare Part D drug program.

Read the full article.

Related Content